Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.
about
Role of angiotensin AT(2) receptors in natriuresis: Intrarenal mechanisms and therapeutic potentialAT2 receptor activities and pathophysiological implicationsThe intrarenal generation of angiotensin II is required for experimental hypertensionUpdate on RAAS Modulation for the Treatment of Diabetic Cardiovascular DiseaseAntagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosisSystemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptorsMetabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actSodium-potassium-adenosinetriphosphatase-dependent sodium transport in the kidney: hormonal controlBlood Pressure and the Renal Actions of AT2 Receptors.Update on angiotensin AT2 receptors.AT2 Receptors: Potential Therapeutic Targets for Hypertension.Angiotensin II type 2 receptor regulates ROMK-like K⁺ channel activity in the renal cortical collecting duct during high dietary K⁺ adaptationThe angiotensin II type 2 receptor and the kidney.The intrarenal renin-angiotensin and dopaminergic systems: control of renal sodium excretion and blood pressureIdentification and characterization of a functional mitochondrial angiotensin system.Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors.Developmental effect of antenatal exposure to betamethasone on renal angiotensin II activity in the young adult sheep.Hypotensive Response to Angiotensin II Type 2 Receptor Stimulation in the Rostral Ventrolateral Medulla Requires Functional GABA-A Receptors.Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteriesTowards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.Angiotensin AT2 receptors: cardiovascular hope or hype?Hypotensive and sympathoinhibitory responses to selective central AT2 receptor stimulation in spontaneously hypertensive rats.Activation of central angiotensin type 2 receptors suppresses norepinephrine excretion and blood pressure in conscious ratsInsights into angiotensin II receptor function through AT2 receptor knockout mice.Transgenic mice for studies of the renin-angiotensin system in hypertension.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].The kallikrein-kinin system as a regulator of cardiovascular and renal function.Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II.The Angiotensin II Type 2 Receptor in Brain Functions: An Update.A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in TaiwanReceptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.Vascular biology of angiotensin and the impact of physical activity.Early life stress enhances angiotensin II-mediated vasoconstriction by reduced endothelial nitric oxide buffering capacityImmune and inflammatory role in renal disease.Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.Imbalance of angiotensin type 1 receptor and angiotensin II type 2 receptor in the rostral ventrolateral medulla: potential mechanism for sympathetic overactivity in heart failure.Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted miceThe angiotensin II type 2 receptor in renal disease.
P2860
Q26825135-1576C659-942E-4A05-AC55-CCD932460A2AQ26829592-217914EC-5761-4B32-906B-901FB44C257DQ27025017-5A0B35FF-2B3D-4A0D-AD0E-0E781269F04AQ28077454-91A82182-0CC6-4A0B-A9FB-5F2148F8A4B0Q28362086-3767525A-2D6A-401E-B64C-3042BCB813D3Q28364369-1A85F1AF-2FBB-49C1-8EE9-83FECA21FFD0Q28390079-09A91C70-BB86-4A7F-B0AA-6828134702BFQ28645766-9B55FFE4-D8AE-4E93-AC6E-76CE1D612CD0Q30253015-548E5D08-9CB6-4E14-8C49-DB076BE0A3DFQ30275321-C504ECC2-42E8-4549-8EF6-4966D4A35208Q30275852-4091E191-1F4B-4EC2-B239-95F328228EAFQ30370554-82080756-9631-49E9-AFE5-13BF61FA9DF6Q30413945-32B6FBFC-7A56-45CB-B062-F481A5F6F6E8Q30414541-CABAFFDA-FB7F-4799-BC97-4300DE2AFD3DQ30427934-B42FD936-D84A-4C83-9390-E0460F7ACB51Q30432916-2D94BDF3-9465-430F-AA13-0AB2987B0635Q32032127-2D6ED41E-82EB-4CFD-8C8B-964255ADB3E9Q33783940-DBB67E1D-20D8-4308-B548-2F8B2C5C1B62Q33809582-1D8D2C02-1A40-4186-A087-4B6A7D532B3FQ33894083-E478DE6C-614C-4F5D-83FB-C3D3D73DC790Q33928318-05B726EC-D8FF-4F2F-A4FA-263DB6CA30BBQ34990858-8D0748B4-0E2E-4C43-9BAB-064777494AF1Q35045801-60B74C7D-D154-4F11-8CE0-7E359D70DD5FQ35601958-97534AE2-93D3-4D03-B294-8D6112E610A6Q35777568-C670AC45-E6A8-4CE3-8C03-4BAE800BBD10Q35850538-FCFCF7D0-11A7-49D7-B668-887220C2B913Q35850586-D7410345-E212-48AA-B88A-522C4924A949Q36241932-6ACF017D-F898-40DA-8ECB-D6534C353332Q36389061-6ABE3E73-3480-4716-96C8-87958DD9F8E4Q36462773-A634904B-6618-414A-9195-3D849A89E4F2Q36520049-E1B1E1B1-87B2-4087-9087-DAC42294386FQ36759789-78D9A9FD-1397-46E9-9429-0533CEEFC0C2Q37050391-69F7527F-92A0-46C2-BE03-29FC9B597DCEQ37112560-E118EF53-0DFC-49B5-9E2C-E11DCA911419Q37125506-B6C3B9EB-046D-41DD-B1E9-06317A4515DDQ37243199-76A7C653-8C3D-480E-8A0D-B370EC4566AEQ37324997-441EF67F-2F9F-47C2-AE9F-F5AA0E6C0C7BQ37383468-52008912-31E0-47A8-ABA5-DBA99D73F56EQ37461915-701B9DA8-CBB3-4FC5-8B44-34F7051CD701Q37622566-92DD5410-2D72-4906-9F9D-07AAEBA93F47
P2860
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@ast
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@en
type
label
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@ast
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@en
prefLabel
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@ast
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@en
P2093
P2860
P356
P1476
Sustained hypersensitivity to ...... -2 (AT2) angiotensin receptor.
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.11.6506
P407
P577
1999-05-01T00:00:00Z